In a latest development in connection with the CDSCO bribery case, the Central Bureau of Investigation (CBI) has moved the Delhi High court seeking custodial remand of all the five accused who were allegedly involved in waiving the Phase 3 .
In the latest development involving Biocon, the Bengaluru-based biopharmaceutical company has brought an external law firm onboard to review its governance process.
In a latest development in connection with the CDSCO bribery case, the Central Bureau of Investigation (CBI) on Tuesday arrested all the remaining accused, who were allegedly involved in waiving the Phase-3 trial of Insulin Aspart Injection of Biocon Biologics.
The investigative agency has said that Joint Drugs Controller S. Eswara Reddy allegedly received a Rs 4 lakh bribe to waive the phase three clinical trial of the Insulin Aspart injection, a product of Biocon Biologics.
In the latest development in connection with the CDSCO bribery case, the Central Bureau of Investigation (CBI) on Tuesday arrested all the remaining accused, who were allegedly involved in waiving the Phase-3 trial of "Insulin Aspart .